UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055961
Receipt number R000063922
Scientific Title Intervention of a Nursing Support Program for Work Continuation in Cancer Patients Undergoing Outpatient Treatment: A Randomized Controlled Trial
Date of disclosure of the study information 2024/10/28
Last modified on 2025/11/04 10:47:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intervention of a Nursing Support Program for Work Continuation in Cancer Patients Undergoing Outpatient Treatment: A Randomized Controlled Trial

Acronym

Intervention of a Nursing Support Program for Work Continuation in Cancer Patients Undergoing Outpatient Treatment: A Randomized Controlled Trial

Scientific Title

Intervention of a Nursing Support Program for Work Continuation in Cancer Patients Undergoing Outpatient Treatment: A Randomized Controlled Trial

Scientific Title:Acronym

Intervention of a Nursing Support Program for Work Continuation in Cancer Patients Undergoing Outpatient Treatment: A Randomized Controlled Trial

Region

Japan


Condition

Condition

Cancer

Classification by specialty

Medicine in general Surgery in general Nursing
Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the feasibility of a nursing support program intervention for work continuation in cancer patients undergoing outpatient treatment developed based on the theory of self-efficacy
Confirmation of the following: (1) Prospect of efficacy for a nursing support program intervention, (2) Completion of the study

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Self-efficacy scale scores

Key secondary outcomes

1) Number and percentage of patients who completed each intervention
2) Employment status (working hours and days)
3) Quality of life (QOL)
4) Psychological stress


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Individual consultations based on a nursing support program grounded in self-efficacy will be conducted by nurses.

Interventions/Control_2

Control group: receives standard outpatient care and nursing as usual

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1)Cancer patients who are continuing to work
2)Aged between 18 and 65 years old
3)Patients who have started outpatient treatment within the last 6 months
4)Patients with an ECOG Performance Status of 0 or 1
5)Patients who have provided written consent to participate in this study
6)Patients who are capable of verbal communication in Japanese
7)Patients whose physical and mental condition allows for a 60 minute interview, as determined by the attending physician and nurse

Key exclusion criteria

1)Individuals who will reach the mandatory retirement age during the study period
2)Individuals with cognitive impairments or other conditions that make verbal communication difficult
3)Patients scheduled for additional inpatient treatment, such as preoperative adjuvant therapy
4)Individuals whose condition has worsened due to cancer or other diseases, and whose prognosis is determined by the attending physician to be less than 6 months
5)Individuals deemed inappropriate by the principal investigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Masamitsu
Middle name
Last name Kobayashi

Organization

Toho University

Division name

Faculty of Nursing

Zip code

143-0015

Address

5-21-16 Omorinishi, Ota-ku, Tokyo, Japan

TEL

03-3762-9236

Email

masamitsu4k26@gmail.com


Public contact

Name of contact person

1st name Masamitsu
Middle name
Last name Kobayashi

Organization

Toho University

Division name

Faculty of Nursing

Zip code

143-0015

Address

5-21-16 Omorinishi, Ota-ku, Tokyo, Japan

TEL

03-3762-9236

Homepage URL


Email

masamitsu4k26@gmail.com


Sponsor or person

Institute

Toho University

Institute

Department

Personal name



Funding Source

Organization

JSPS KAKENHI Grant Number 23K10015

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saint Lukes International University

Address

10-1 Akashi-cho, Chuo-ku, Tokyo, Japan

Tel

03-3543-6391

Email

masamitsu4k26@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 10 Month 28 Day

Date of IRB

2024 Year 05 Month 22 Day

Anticipated trial start date

2024 Year 11 Month 01 Day

Last follow-up date

2026 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 10 Month 28 Day

Last modified on

2025 Year 11 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063922